Home ›
Companies in Liquidation ›
Macrophage Pharma Limited Is Macrophage Pharma Limited in creditors' voluntary liquidation?
Last verified 5 June 2026
Yes, Macrophage Pharma Limited (company number 09369013) entered creditors' voluntary liquidation on 16 February 2023, by its creditors. Stephen Robert Leslie Cork of Cork Gully LLP was appointed as liquidator.
Do you deal with companies like Macrophage Pharma Limited? Add up to 5 companies free. We'll email you the day one enters administration.
Free, no card. We'll send a one-click sign-in link, no password to remember.
Prefer the earlier signs? Protect catches the pattern that builds, well before it's official. See how it works →
Macrophage Pharma Limited is now in creditors' voluntary liquidation. Below are the key dates, the directors, the public-record timeline that led here, and what the liquidation means if you are a creditor, employee, customer or supplier.
How the case progressed
Administration
16 February 2022
Creditors' voluntary liquidation
16 February 2023 · Cork Gully LLP
Company at a glance
| Status | In Creditors' Voluntary Liquidation |
|---|
| Company number | 09369013 |
|---|
| Previously known as | - Macrophage Therapeutics Limited, Dec 2014 to Feb 2015
|
|---|
| Incorporated | 29 December 2014 (12 years old) |
|---|
| Registered office | C/O Cork Gully Llp 40, London, WC2N 6NJ |
|---|
| Nature of business (SIC) | 72110: Research and experimental development on biotechnology |
|---|
| Date entered creditors' voluntary liquidation | 16 February 2023 |
|---|
| Liquidator | Stephen Robert Leslie Cork, Cork Gully LLP (licensed insolvency practitioner) |
|---|
| Official notice | View the official notice ↗ |
|---|
| Statement of Affairs | Filed 28 December 2022, declared assets & liabilities ↗ |
|---|
| Public register | View filing history ↗ |
|---|
About the business
Macrophage Pharma Limited is a UK limited company based in London, incorporated in 2014 and 9 years old when the liquidator was appointed. Its registered activity is research and experimental development on biotechnology (SIC 72110). There have been 11 director appointments since incorporation, of which 2 were on the board when the liquidator was appointed, alongside 1 person with significant control.
Directors
11 people have been appointed as directors of Macrophage Pharma Limited.
DirectorStatusAppointedResigned
+5 former directors · resigned 2016 to 2021
A director resignation shortly before an insolvency is a matter of public record; it does not by itself imply wrongdoing.
Persons with significant control
Individuals or entities with significant influence or control.
Crt Pioneer Gp Limited
corporate entity person with significant control
Ownership of shares 25-50%Voting rights 25-50%
1 ceased control
- Crt Pioneer Fund Lp · ceased 18 Apr 2019
What happened
EventDateType
Liquidators' statement of receipts and payments14 April 2026LIQ03
Liquidators' statement of receipts and payments to 2025-02-158 April 2025LIQ03
Liquidators' statement of receipts and payments to 2024-02-1525 April 2024LIQ03
Registered office address changed from C/O Cork Gully Llp 6 Snow Hill London EC1A 2AY England to C/O Cork Gully Llp 40 Villiers Street London WC2N 6NJ on 2023-12-2121 December 2023AD01 Termination of appointment of Cheryl Doreen Zimberlin as a director on 2023-10-0431 October 2023TM01 +61 earlier events · 2015 to 2023
Appointment of a voluntary liquidator8 March 2023600
Notice of move from Administration case to Creditors Voluntary Liquidation16 February 2023AM22 Statement of administrator's proposal28 December 2022AM03 Statement of affairs with form AM02SOA/AM02SOC28 December 2022AM02 Administrator's progress report14 September 2022AM10 Termination of appointment of Venkateshwar Alumalla Reddy as a director on 2022-02-0927 May 2022TM01 Result of meeting of creditors14 April 2022AM07
Termination of appointment of Michael Moore as a director on 2022-02-241 March 2022TM01 Appointment of an administrator16 February 2022AM01 Registered office address changed from 30 Broad Street Great Cambourne Cambridge Cambridgeshire CB23 6HJ United Kingdom to C/O Cork Gully Llp 6 Snow Hill London EC1A 2AY on 2022-02-1010 February 2022AD01 Confirmation statement made on 2021-12-29 with no updates7 January 2022CS01 Director's details changed for Dr Venkateshwar Alumalla Reddy on 2021-08-067 January 2022CH01 Appointment of Mrs Cheryl Doreen Zimberlin as a director on 2021-09-205 October 2021AP01 Termination of appointment of Hakan Goker as a director on 2021-09-205 October 2021TM01 Accounts for a small company made up to 2021-03-3120 August 2021AA Appointment of Dr Venkateshwar Alumalla Reddy as a director on 2021-06-011 June 2021AP01 Termination of appointment of Soren Bregenholt Frederiksen as a director on 2021-05-311 June 2021TM01 Termination of appointment of Ian Alexander Francis Miscampbell as a director on 2021-03-1824 March 2021TM01 Termination of appointment of Anker Lundemose as a director on 2021-03-1924 March 2021TM01 Confirmation statement made on 2020-12-29 with updates25 January 2021CS01 Registered office address changed from 30 Broad Street Great Cambourne Cambridge CB23 6HJ England to 30 Broad Street Great Cambourne Cambridge Cambridgeshire CB23 6HJ on 2020-12-011 December 2020AD01 Registered office address changed from 4 Claridge Court Lower Kings Road Berkhamsted Hertfordshire HP4 2AF England to 30 Broad Street Great Cambourne Cambridge CB23 6HJ on 2020-10-088 October 2020AD01 Accounts for a small company made up to 2020-03-3126 August 2020AA Statement of capital following an allotment of shares on 2020-04-1711 May 2020SH01 Director's details changed for Dr Soren Bregenholt. on 2020-02-1111 February 2020CH01 Confirmation statement made on 2019-12-29 with updates8 January 2020CS01 Accounts for a small company made up to 2019-03-311 November 2019AA Termination of appointment of Stephan Christgau as a director on 2019-10-1516 October 2019TM01 Notification of Crt Pioneer Gp Limited as a person with significant control on 2019-04-188 October 2019PSC02 Cessation of Crt Pioneer Fund Lp as a person with significant control on 2019-04-188 October 2019PSC07 Director's details changed for Mr Soren Bregenholt Bregenholt. on 2019-10-011 October 2019CH01 Director's details changed for Mr Soren Bregenholt Frederiksen on 2019-07-011 October 2019CH01 Appointment of Mr Soren Bregenholt Frederiksen as a director on 2019-07-0121 August 2019AP01 Appointment of Dr Anker Lundemose as a director on 2019-05-0113 August 2019AP01 Statement of capital following an allotment of shares on 2019-04-1818 April 2019SH01 Statement of capital following an allotment of shares on 2018-10-237 March 2019SH01 Statement of capital following an allotment of shares on 2018-03-145 March 2019SH01 Confirmation statement made on 2018-12-29 with updates14 January 2019CS01 Termination of appointment of Steven John Powell as a director on 2018-11-3014 January 2019TM01 Appointment of Dr Michael Moore as a director on 2018-03-0111 January 2019AP01 Accounts for a small company made up to 2018-03-3111 October 2018AA Registered office address changed from St. Stephens House Arthur Road Windsor Berkshire SL4 1RU England to 4 Claridge Court Lower Kings Road Berkhamsted Hertfordshire HP4 2AF on 2018-06-011 June 2018AD01 Confirmation statement made on 2017-12-29 with updates7 February 2018CS01 Accounts for a small company made up to 2017-03-3120 November 2017AA Appointment of Dr Hakan Goker as a director on 2017-07-0711 September 2017AP01 Registered office address changed from 4 Claridge Court Lower Kings Road Berkhamsted Hertfordshire HP4 2AF to St. Stephens House Arthur Road Windsor Berkshire SL4 1RU on 2017-03-077 March 2017AD01 Confirmation statement made on 2016-12-29 with updates11 January 2017CS01 Statement of capital following an allotment of shares on 2016-11-2921 December 2016SH01 Sub-division of shares on 2016-11-2915 December 2016SH02 Particulars of variation of rights attached to shares15 December 2016SH10 Appointment of Dr Mark Regnerus Leonardus Krul as a director on 2016-11-2929 November 2016AP01 Appointment of Dr Stephan Christgau as a director on 2016-11-2929 November 2016AP01 Termination of appointment of Robert Ian James as a director on 2016-11-2929 November 2016TM01 Total exemption small company accounts made up to 2016-03-3117 August 2016AA Annual return made up to 2015-12-29 with full list of shareholders27 January 2016AR01 Current accounting period extended from 2015-12-31 to 2016-03-3122 January 2016AA01 Appointment of Dr Steven John Powell as a director on 2016-01-0120 January 2016AP01 Certificate of change of name27 February 2015CERTNM Change of name notice13 February 2015CONNOT
Incorporation29 December 2014NEWINC What this means for you
If you are a creditor
Submit your proof of debt to the liquidator (Cork Gully LLP). Once liquidation begins, no creditor can start or continue legal action without the court's permission. Unsecured creditors rank after secured and preferential creditors and are usually paid last, often only a portion.
Owed money by a company in liquidation →If you are an employee
Employees are preferential creditors for certain unpaid wages and holiday pay, and may be able to claim from the Redundancy Payments Service if roles are made redundant.
Employee rights and redundancy pay →If you are a customer
Deposits paid are usually unsecured claims. Contracts may be terminated by the liquidator. Contact the liquidator about outstanding work or refunds.
What customers can recover →If you are a supplier
Goods supplied before the liquidation began are an unsecured claim. Check whether any retention-of-title clause lets you identify and recover specific goods.
How retention of title works →Don't be the last to know next time
Most suppliers only find out a customer has failed once it is announced. By then it is too late. Protect monitors every company you sell to and emails you as the warning signs build, well before it becomes official. We can't stop a customer failing, but you'll never be the last to know, and you'll know you did all you could.
See how Protect works, £24/mo →Other companies in creditors' voluntary liquidation
Related guides
The bigger picture
Frequently asked questions
- Is Macrophage Pharma Limited in creditors' voluntary liquidation?
- Yes. Macrophage Pharma Limited (company number 09369013) entered creditors' voluntary liquidation on 16 February 2023, by its creditors. Stephen Robert Leslie Cork of Cork Gully LLP was appointed as liquidator.
- Who is the liquidator of Macrophage Pharma Limited?
- Stephen Robert Leslie Cork, a licensed insolvency practitioner at Cork Gully LLP, was appointed liquidator of Macrophage Pharma Limited on 16 February 2023. Creditors can contact the liquidator directly to submit a claim.
- What does Macrophage Pharma Limited do?
- Macrophage Pharma Limited's registered nature of business is research and experimental development on biotechnology (SIC 72110).
- Where is Macrophage Pharma Limited based?
- Macrophage Pharma Limited's registered office is C/O Cork Gully Llp 40, London, WC2N 6NJ. The registered office is the address held on the public register, which is not always the trading address.
- When was Macrophage Pharma Limited founded?
- Macrophage Pharma Limited was incorporated on 29 December 2014, 9 years before the liquidator was appointed.
- What is Macrophage Pharma Limited's company number?
- Macrophage Pharma Limited's registered company number is 09369013.
- Who has significant control of Macrophage Pharma Limited?
- 1 active person with significant control over Macrophage Pharma Limited is on the register: Crt Pioneer Gp Limited.
- What does liquidation mean for creditors of Macrophage Pharma Limited?
- Liquidation is the formal wind-up of a company. Once it begins, the liquidator collects assets, settles claims in statutory order (secured, preferential, then unsecured) and distributes whatever remains. Unsecured creditors often recover only a portion of what they are owed, and sometimes nothing.
- How long does liquidation take?
- Most liquidations run for 12 to 24 months, longer where the company has complex assets, litigation, or ongoing trading. Annual progress reports are filed by the liquidator until the company is dissolved at the end of the process.
- Will creditors get paid in Macrophage Pharma Limited's liquidation?
- Secured creditors are paid from the assets they hold a charge over. Preferential creditors (employee wages up to limits, pension contributions, HMRC for certain taxes) come next. Unsecured creditors share whatever remains, which may be nothing. The Statement of Affairs, when filed, sets out the liquidator's estimate at the point of appointment.
Report an error on this page·Not financial, credit or legal advice.